Moxetumomab Pasudotox-tdfk and Ogivri Intravenous
Determining the interaction of Moxetumomab Pasudotox-tdfk and Ogivri Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: trastuzumab
Brand name: Herceptin, Kanjinti, Ogivri
Synonyms: Ogivri, Ogivri Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Ohm Allergy Relief
- Moxetumomab Pasudotox-tdfk-Olanzapine
- Moxetumomab Pasudotox-tdfk-Olanzapine and Fluoxetine
- Moxetumomab Pasudotox-tdfk-Olanzapine and Fluoxetine Capsules
- Moxetumomab Pasudotox-tdfk-Olanzapine Extended-Release Injection
- Moxetumomab Pasudotox-tdfk-Olanzapine injection
- Ogivri Intravenous-Moxetumomab pasudotox-tdfk Intravenous
- Ogivri Intravenous-Moxifloxacin
- Ogivri Intravenous-Moxifloxacin (Systemic)
- Ogivri Intravenous-Moxifloxacin Hydrochloride
- Ogivri Intravenous-Moxifloxacin Injection
- Ogivri Intravenous-Moxifloxacin Intravenous